Albert Bourla, CEO chief executive of US pharmaceutical giant Pfizer, was faced with a series of tough questions about the efficacy

The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at the AIIMS.